Sinovac’s CoronaVac approved
The SA Health Products Regulatory Authority (SAHPRA) has approved the use of the CoronaVac Covid-19 vaccine. The authorisation was based on the safety, quality and efficacy data submitted to it by the importer of the vaccine between March and June but the is subject to a number of conditions. This include that the applicant submits the final results of ongoing clinical studies. SAHPRA described the side-effects of the vaccine as mild.
CoronaVac is administered as two doses, with the second dose administered between 14 and 28 days after the first dose.